Molecular Partners AG (MOLN) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Molecular Partners AG (MOLN) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $162.4M, listed on NASDAQ, employing roughly 134 people, carrying a beta of 0.68 to the broader market. Molecular Partners AG operates as a clinical-stage biopharmaceutical company, specializing in the identification, advancement, and commercialization of innovative therapeutic proteins. Led by Patrick Amstutz, public since 2021-06-16.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for MOLN as of 2026-08-23; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →